Sonoma Pharmaceuticals, Inc. - stock earnings
SNOA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -866000 USD | 3.1 million USD |
| 2023Q3 | -1.5 million USD | 2.7 million USD |
| 2023Q2 | -1.4 million USD | 3.4 million USD |
| 2023Q1 | -1.3 million USD | 3.0 million USD |
| 2022Q4 | -1.9 million USD | 2.9 million USD |
| 2022Q3 | -1.0 million USD | 3.3 million USD |
| 2022Q2 | -2.9 million USD | 2.3 million USD |
| 2022Q1 | -2.9 million USD | 2.3 million USD |
| 2021Q4 | -944000 USD | 2.9 million USD |
| 2021Q3 | -100000 USD | 3.7 million USD |
| 2021Q2 | -3.7 million USD | 2.2 million USD |
| 2021Q1 | -3.7 million USD | 2.2 million USD |
| 2020Q4 | -650000 USD | 4.9 million USD |
| 2020Q3 | 120000 USD | 5.8 million USD |
| 2020Q2 | -1.4 million USD | 4.6 million USD |
| 2020Q1 | -1.4 million USD | 4.6 million USD |
| 2019Q4 | -1.1 million USD | 4.7 million USD |
| 2019Q3 | -1.2 million USD | 5.0 million USD |
| 2019Q2 | -3.2 million USD | 4.4 million USD |
| 2019Q1 | -3.2 million USD | 4.4 million USD |
| 2018Q4 | -2.3 million USD | 5.3 million USD |
| 2018Q3 | -2.8 million USD | 4.9 million USD |
| 2018Q2 | -3.5 million USD | 4.4 million USD |
| 2018Q1 | -4.8 million USD | 3.7 million USD |
| 2017Q4 | -3.2 million USD | 4.8 million USD |
| 2017Q3 | -2.9 million USD | 4.3 million USD |
| 2017Q2 | -3.5 million USD | 3.8 million USD |
| 2017Q1 | -2.4 million USD | 4.0 million USD |
| 2016Q4 | 16.2 million USD | 3.4 million USD |
| 2016Q3 | -1.9 million USD | 4.1 million USD |
| 2016Q2 | -2.6 million USD | 3.8 million USD |
| 2016Q1 | -2.9 million USD | 3.5 million USD |
| 2015Q4 | -3.1 million USD | 3.8 million USD |
| 2015Q3 | -1.8 million USD | 4.1 million USD |
| 2015Q2 | -2.3 million USD | 3.7 million USD |
| 2015Q1 | -1.5 million USD | 4.0 million USD |
| 2014Q4 | -5.9 million USD | 3.2 million USD |
| 2014Q3 | -718000 USD | 3.3 million USD |
| 2014Q2 | -70000 USD | 3.4 million USD |
| 2014Q1 | 7.5 million USD | 2.9 million USD |
| 2013Q4 | -611000 USD | 3.3 million USD |
| 2013Q3 | -1.4 million USD | 4.1 million USD |
| 2013Q2 | -1.7 million USD | 3.4 million USD |
| 2013Q1 | -2.4 million USD | 3.3 million USD |
| 2012Q4 | -1.9 million USD | 3.5 million USD |
| 2012Q3 | -1.5 million USD | 4.5 million USD |
| 2012Q2 | 445000 USD | 4.1 million USD |
| 2012Q1 | -1.8 million USD | 3.4 million USD |
| 2011Q4 | -2.5 million USD | 2.8 million USD |
| 2011Q3 | -839000 USD | 3.7 million USD |
| 2011Q2 | -2.2 million USD | 2.9 million USD |
| 2011Q1 | -1.7 million USD | 2.7 million USD |
| 2010Q4 | -2.2 million USD | 2.3 million USD |
| 2010Q3 | -1.6 million USD | 2.5 million USD |
| 2010Q2 | -2.4 million USD | 2.3 million USD |
| 2010Q1 | -1.5 million USD | 2.2 million USD |
| 2009Q4 | -1.3 million USD | 1.6 million USD |
| 2009Q3 | -1.9 million USD | 1.7 million USD |
| 2009Q2 | -3.5 million USD | 1.8 million USD |
| 2009Q1 | -2.2 million USD | 1.5 million USD |
| 2008Q4 | -3.3 million USD | 1.2 million USD |
| 2008Q3 | -6.9 million USD | 1.5 million USD |
| 2008Q2 | -5.2 million USD | 1.2 million USD |
| 2008Q1 | -4.5 million USD | 926000 USD |
| 2007Q4 | -5.3 million USD | 1.1 million USD |
| 2007Q3 | -5.5 million USD | 977000 USD |
| 2007Q2 | -5.0 million USD | 866000 USD |
| 2007Q1 | -6.3 million USD | 1.2 million USD |
| 2006Q4 | -4.8 million USD | 1.1 million USD |
| 2006Q3 | -4.3 million USD | 1.2 million USD |
| 2006Q2 | -4.3 million USD | 1.2 million USD |
| 2006Q1 | -6.7 million USD | 751000 USD |
| 2005Q4 | -6.7 million USD | 751000 USD |
| 2005Q3 | -4.9 million USD | 541000 USD |
| 2005Q2 | -4.9 million USD | 541000 USD |
| 2005Q1 | -4.1 million USD | 339000 USD |
| 2004Q4 | -4.1 million USD | 339000 USD |
| 2004Q3 | -4.1 million USD | 339000 USD |
| 2004Q2 | -4.1 million USD | 339000 USD |
SNOA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.2 million USD | 13.3 million USD |
| 2022 | -5.1 million USD | 12.6 million USD |
| 2021 | -4.6 million USD | 18.6 million USD |
| 2020 | -2.9 million USD | 18.9 million USD |
| 2019 | -11.8 million USD | 19.0 million USD |
| 2018 | -14.3 million USD | 16.7 million USD |
| 2017 | 9.3 million USD | 12.8 million USD |
| 2016 | -10.2 million USD | 15.1 million USD |
| 2015 | -8.2 million USD | 13.9 million USD |
| 2014 | 3.7 million USD | 13.7 million USD |
| 2013 | -5.4 million USD | 15.5 million USD |
| 2012 | -7.3 million USD | 12.7 million USD |
| 2011 | -7.9 million USD | 9.8 million USD |
| 2010 | -8.2 million USD | 7.4 million USD |
| 2009 | -17.7 million USD | 5.4 million USD |
| 2008 | -20.3 million USD | 3.8 million USD |
| 2007 | -19.8 million USD | 4.5 million USD |
| 2006 | -23.1 million USD | 2.6 million USD |
| 2005 | -16.5 million USD | 1.4 million USD |
| 2004 | -7.3 million USD | 902000 USD |
| 2003 | -1.6 million USD | 2.5 million USD |
| 2002 | -167000 USD | 2.0 million USD |
SNOA
Price: $0.16
52 week price:
Earnings Per Share: -0.82 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 313242
Ebitda: -12.7 millionMarket Capitalization: 2.7 million